Publicaciones en colaboración con investigadores/as de University College London (2)

2020

  1. Single-subject structural cortical networks in clinically isolated syndrome

    Multiple Sclerosis Journal, Vol. 26, Núm. 11, pp. 1392-1401

2018

  1. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415